The vultures are circling – be very careful who you talk to

This email trail is cut and pasted as it occurred so should be read from the bottom up. Some names and email addresses have been removed to maintain confidentiality.  Approaches which at first sight may appear to be a genuine scientific inquiry may be aimed at working out how to carve up the best bits of the NHS for the private sector. We should all be very careful who we talk to.

Well done to the ethical consultant physician who received this approach.

Hi Tom

 I feel very uncomfortable about sharing ‘intellectual property’ on that basis as it may lead to a greater likelihood of NHS services being outsourced.

 I am sorry I am not able to assist you.

 Best wishes

XXXXX

—————————————————————

From: TGibson@uk.ey.com [TGibson@uk.ey.com]
Sent: 02 June 2014 15:16
To:XXXXX
Subject: RE: EY research – healthcare system trends in the management of Chronic Kidney Disease

Hi XXXXX,

Of course, happy to answer any question you have.

Our work is focussed around understanding and developing new ways in which private providers could work with public healthcare that would reduce pressure and spend for NHS whilst focussing on optimising outcomes for patients.

We work with a lot of clients in this area, and are currently working with a client to develop new ways in which they could offer services to the NHS specifically around CKD and dialysis.

We are exploring both alternative payment/reimbursement structures as well as partnerships or outsourcing models.

We would like to discuss these with you to gain your insight, and understand your views on the key challenges being faced by the system.

The purpose of this would be to validate and test ideas that we could then propose to be implemented.

All of our notes and reports would be fully anonymised and we would not reference your involvement.

Kind regards,
Tom Gibson

 
Tom Gibson | Life Sciences
Ernst & Young LLP
1 More London Place, London SE1 2AF, United Kingdom
Office: +44 (0)20 795 14013 | Mobile: +44 (0)7785 444 079 | tgibson@uk.ey.com
Website: http://www.ey.com

——————————————————————

From: xxxxxxxxxx
To: “‘TGibson@uk.ey.com'” <TGibson@uk.ey.com>,
Date: 02/06/2014 11:46
Subject: RE: EY research – healthcare system trends in the management of Chronic Kidney Disease

OK Tom. I understand. 

Perhaps you could just give me a little context of what you will be doing with the information you gather.
XXXXX 

———————————————————————————————– 
From: TGibson@uk.ey.com [mailto:TGibson@uk.ey.com]
Sent: 02 June 2014 10:38
To:XXXXX
Cc: 

Subject: RE: EY research – healthcare system trends in the management of Chronic Kidney Disease
 
Hi XXXXX,

Hope you had a good weekend.

We unfortunately cannot offer any commercial arrangements for this piece of work.

I know that this is not the most ideal situation but we would be happy to schedule outside normal working hours, or even a quick 10 minutes to just understand your views on a couple of areas if that would make it easier?

We would of course share with you some of our insight from this work, as well as a summary of the wider conversations we have.

We would obviously be hugely grateful for any time that you could spare.

Kind regards,
Tom Gibson

   
Tom Gibson | Life Sciences
Ernst & Young LLP
1 More London Place, London SE1 2AF, United Kingdom
Office: +44 (0)20 795 14013 | Mobile: +44 (0)7785 444 079 | tgibson@uk.ey.com
Website: http://www.ey.com
From: XXXXX
To: “‘TGibson@uk.ey.com'” <TGibson@uk.ey.com>,
Cc:
Date: 30/05/2014 09:58
Subject: RE: EY research – healthcare system trends in the management of Chronic Kidney Disease

  Dear Tom

I am sure I can contribute significantly to your project.
I have attached a paper recently published describing our work.
We are in the process of preparing a project to spread the surveillance system described in it across the UK.
 
I do not wish to be mercenary but I am still not clear of the commercial aspects of your involvement in this. I have nothing against EY  but time is money. I do not wish to gain personally but I am paid by the NHS to work for the public.
 
Perhaps you could clarify the arrangements, please.
 
Best wishes
XXXXX

———————————————————

From: TGibson@uk.ey.com [mailto:TGibson@uk.ey.com]
Sent: 29 May 2014 20:35
To: XXXXX
Subject: RE: EY research – healthcare system trends in the management of Chronic Kidney Disease

 
Hi XXXXX,

Thank you for getting back to me so quickly.

One of the things that we have seen in CKD management is that there is an opportunity to focus on prevention, early diagnostic and patient follow-up programs, avoiding high costs associated to those patients in the later stage of the pathway.

We would like to get your perspective around this, approaches to commissioning of services including a prevention component, as well as key challenges and pressures being faced.

We propose a short call of about 20 minutes for us to discuss this, as well as getting your insight into any wider issues, opportunities and trends that are being, or you think can be, explored in the UK.

We propose to then circle back round with you to share our findings and insights from the wider interviews we conduct; within a week to 10 days of our call.

Please let us know when you might be available to talk.
Kind regards,
Tom Gibson

   
Tom Gibson | Life Sciences Advisory
Ernst & Young LLP
1 More London Placdon SE1 2AF, United Kingdom
Office: +44 (0)20 795 14013 | Mobile: +44 (0)7785 444 079 | tgibson@uk.ey.com
Website: http://www.ey.com

 

From: XXXXXXXXX 
To:  “TGibson@uk.ey.com” <TGibson@uk.ey.com>,
Date: 29/05/2014 12:56
Subject: RE: EY research – healthcare system trends in the management of Chronic Kidney Disease

 

Dear Tom

I may be willing to assist with your research.
What are the terms of this commitment?
Best wishes
XXXXX

————————————————————–
From: TGibson@uk.ey.com [mailto:TGibson@uk.ey.com]
Sent: 29 May 2014 11:55
To: Dr XXXX secretary
Subject: EY research – healthcare system trends in the management of Chronic Kidney Disease

Hi Dr XXXXX secretary,

We spoke on the phone briefly just now as I am trying to get in contact with Dr XXXXX.

I am part of the Global Life Sciences Team at Ernst & Young (EY).

We are conducting research at a European Level exploring the main healthcare system trends in the management of Chronic Kidney Disease, with a focus on Dialysis and on the collaboration between public providers, private providers and other stakeholders.

Dr XXXX’s insight as a senior professional in this field would be enormously valuable to us and we would be very grateful if he could spare 20 minutes for us to schedule a brief phone call between now and 5th June (next Thursday) to discuss his point of view in a few areas.

Happy to call back to give some more information if that would be helpful, and find a time that suits.

Thanks for your help.

Kind regards,
Tom Gibson

Tom Gibson | Life Sciences Advisory

Ernst & Young LLP

1 More London Place, London SE1 2AF, United Kingdom

Office: +44 (0)20 795 14013 | Mobile: +44 (0)7785 444 079 | tgibson@uk.ey.com<mailto:tgibson@uk.ey.com>

Website: http://www.ey.com<http://www.ey.com/>

 

Advertisements

One comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s